84629-61-8

84629-61-8 structure

Name: Darenzepine
Chemical Name: 6H-Dibenz[b,e]azepin-6-one, 5,11-dihydro-11-[2-(4-methyl-1-piperazinyl)-2-oxoethylidene]-, (11E)
CAS Number: 84629-61-8
Molecular Formula: C₂₁H₂₁N₃O₂
Molecular Weight: 347.41000
Catalog: Signaling Pathways GPCR/G Protein mAChR
Create Date: 2017-06-28 07:07:41
Modify Date: 2025-09-28 17:02:58
Darenzepine is a muscarinic receptor inhibitor extracted from patent US 20170095465 A1.

Name	6H-Dibenz[b,e]azepin-6-one, 5,11-dihydro-11-[2-(4-methyl-1-piperazinyl)-2-oxoethylidene]-, (11E)
Synonyms	Darenzepine 11H-Dibenz[b,e]azepine, piperazine deriv. DARENZEPINE Piperazine, 1-[(5,6-dihydro-6-oxo-11H-dibenz[b,e]azepin-11-ylidene)acetyl]-4-methyl-, (E)-

Description	Darenzepine is a muscarinic receptor inhibitor extracted from patent US 20170095465 A1.
Related Catalog	Signaling Pathways >> GPCR/G Protein >> mAChR Signaling Pathways >> Neuronal Signaling >> mAChR Research Areas >> Neurological Disease
Target	muscarinic receptor[1]
In Vitro	Darenzepine is a muscarinic receptor inhibitor which is useful for the treatment of CNS disorders[1].
References	[1]. Eric Elenko, et al. Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation. US 20170095465 A1.